|
Moraga, Ignacio; Wernig, Gerlinde; Wilmes, Stephan et al. (2015) Tuning cytokine receptor signaling by re-orienting dimer geometry with surrogate ligands. Cell 160:1196-208
|
|
Pachynski, Russell K; Scholz, Alexander; Monnier, Justin et al. (2015) Evaluation of Tumor-infiltrating Leukocyte Subsets in a Subcutaneous Tumor Model. J Vis Exp :
|
|
Corces-Zimmerman, M Ryan; Hong, Wan-Jen; Weissman, Irving L et al. (2014) Preleukemic mutations in human acute myeloid leukemia affect epigenetic regulators and persist in remission. Proc Natl Acad Sci U S A 111:2548-53
|
|
Koontz, Michael Zach; Horning, Sandra J; Balise, Raymond et al. (2013) Risk of therapy-related secondary leukemia in Hodgkin lymphoma: the Stanford University experience over three generations of clinical trials. J Clin Oncol 31:592-8
|
|
Pachynski, Russell K; Zabel, Brian A; Kohrt, Holbrook E et al. (2012) The chemoattractant chemerin suppresses melanoma by recruiting natural killer cell antitumor defenses. J Exp Med 209:1427-35
|
|
Harshman, Lauren C; Bepler, Gerold; Zheng, Zhong et al. (2010) Ribonucleotide reductase subunit M1 expression in resectable, muscle-invasive urothelial cancer correlates with survival in younger patients. BJU Int 106:1805-11
|
|
Vinayak, Shaveta; Ford, James M (2010) PARP Inhibitors for the Treatment and Prevention of Breast Cancer. Curr Breast Cancer Rep 2:190-197
|
|
Srinivas, Sandy; Harshman, Lauren C (2009) A phase II study of docetaxel and oxaliplatin for second-line treatment of urothelial carcinoma. Chemotherapy 55:321-6
|
|
Harshman, Lauren C; Kuo, Calvin J; Wong, Bryan Y et al. (2009) Increased hemoglobin associated with VEGF inhibitors in advanced renal cell carcinoma. Cancer Invest 27:851-6
|
|
Vinayak, Shaveta; Kurian, Allison W (2009) Statins May Reduce Breast Cancer Risk, Particularly Hormone Receptor-Negative Disease. Curr Breast Cancer Rep 1:148-156
|
Showing the most recent 10 out of 13 publications
